Cross-disciplinary skills

New

Level 1 -

Contracts in biopharmaceutical R&D

Presentation

Why participate?
You want to better understand the different types of contracts that structure research and development activities and the related challenges.
As part of your role, you may be required to review, interpret, or even negotiate contracts related to the company’s R&D activities. However, you may not fully grasp the distinctions or implications between the various contract types. You would like to clarify which type of contract to use in which context and identify the available options and their consequences more effectively.

Training context
From early-stage research to market launch, including preclinical testing, the R&D process leading to the commercialization of a drug involves numerous contractual negotiations — all critical to the company’s successful development.

Learning objectives

  • Identify the different types of contracts according to the chronological stages of biopharmaceutical research and development.
  • Determine the appropriate type(s) of contract based on the specific situation and needs.
  • Explore the strategic clauses in these contracts to better protect the company’s interests.

Teaching methods

Interactive Teaching, Case Studies, Experience Sharing

Audience

This training is intended for business leaders, project managers, researchers, engineers, administrative managers, or anyone involved in strategic decisions regarding the types of contracts to be established in connection with the company’s research and development (R&D) activities and their negotiation.

Prerequisites

No prerequisites required

Duration

1 day, 7 hours

Price

750 € HT (Public)
600 € HT (Membre)
300 € HT (Académique)

Prices: Excluding tax, as the training is not subject to VAT.
In-house training rate: Please contact us.

Trainers

Catalogue de formations-MabDesign-2023.pdf (21)

Mathilde

SALAVIN

Partner lawyer
MCE Carrel

Rating

There is no rating available because this training session was never carried out.

The benefits of our courses

  • Personalized support
  • Skills assessment
  • Certificate of completion
  • Training quality evaluation
  • Accessible to people with disabilities (please contact us)

How to access and deadlines

Registering online or by e-mail is a pre-registration. We will process your request within one week:

  • Contact by e-mail or telephone
  • Sending of administrative and educational documents: training agreement, training programme and positioning questionnaire.

Signing the training agreement commits the company or individual to the training course. Cancellation conditions are specified in the training agreement.

When no session date is specified, pre-registration allows us to note your interest in a programme, and we will keep you informed as soon as a new session is organised.

For more information, contact Daphné Brisard: 02 47 36 63 18 or formation@mabdesign.fr

Jean-Roch Fabreguettes

MEARY

Directeur Médical et Personne Responsable du Centre MEARY de thérapie cellulaire et génique au sein de l’hôpital Saint-Louis à Paris

Jean-Roch Fabreguettes est un spécialiste de la recherche translationnelle et des phases précoces de développement clinique des médicaments de thérapie innovantes (MTI). Pharmacien, titulaire d’un doctorat de l’Université de Montpellier 1, il a travaillé plus de 25 ans dans le domaine et a contribué, pour des équipes académiques comme pour des start-ups, à la réalisation de plus de 30 programmes de recherche sur différents types de MTI : thérapie génique in vivo ou ex vivo, thérapie cellulaire, ingénierie tissulaire… Il est actuellement Directeur Médical et Personne Responsable du Centre MEARY de thérapie cellulaire et génique au sein de l’hôpital Saint-Louis à Paris. Le centre MEARY est une plateforme de l’Assistance Publique – Hôpitaux de Paris (AP-HP), dédiée à la fabrication de médicament de thérapie innovante expérimentaux. Laboratoire membre de l’ISCT, il est autorisé par l’ANSM et dispose d’un certificat GMP. A ce titre Jean-Roch Fabreguettes est impliqué dans le développement clinique et la fabrication de nombreux MTI : CAR-T cells, lymphocytes T régulateurs, cellules stromales mésenchymateuses…

Précédemment, Jean-Roch Fabreguettes a été expert Qualité (CMC) auprès de l’ANSM durant 9 ans et a conseillé différentes sociétés de biotechnologies. Il est un intervenant régulier pour l’Université Paris Cité et un membre actif de l’ISCT et de réseaux nationaux et internationaux sur les MTI (UNI-TC, Join4ATMP).